Purnovate

Purnovate, a wholly-owned subsidiary of Adial Pharmaceuticals, is a pharmaceutical development and chemical company focused on inventing and developing selective, potent, stable, and soluble adenosine analogs for the treatment of diseases and disorders such as pain, cocaine addiction, inflammation, infectious diseases, cancer, asthma, and diabetes.